Figure 1 Eculizumab improved the RBC count (1.96×1012/L vs 2.45×1012/L, p=0.01), levels of Hb (64 g/L vs 83 g/L, p=0.005) and LDH (13.53×ULN vs 3.38×ULN, p=0.028) significantly.